A recent study published in The Lancet refutes the claim that there is a link between Tylenol and autism. The study, which was conducted by scientists from Italy, Sweden, Norway, and the United Kingdom, is a systematic review of the global body of research investigating a possible relationship between acetaminophen (the active ingredient in Tylenol) and childhood neurodevelopmental disorders. The findings of the study are consistent with previous research, which found no evidence that acetaminophen use in pregnancy increases the risk of autism, ADHD, or intellectual disability. Despite the lack of evidence, some pregnant women may still be avoiding acetaminophen due to concerns raised by President Trump's controversial statements. This could have negative consequences for both the mother and baby. Autism researchers are concerned about the opportunity cost of this outsized attention on Tylenol, as it could delay other important research. The study highlights the importance of accurate scientific information and the potential harm caused by misinformation.
